Tuesday, Sep 29, 2026
English News
  • Hyderabad
  • Telangana
  • AP News
  • India
  • World
  • Entertainment
  • Sport
  • Science and Tech
  • Business
  • Rewind
  • ...
    • NRI
    • View Point
    • cartoon
    • My Space
    • Education Today
    • Reviews
    • Property
    • Lifestyle
E-Paper
  • NRI
  • View Point
  • cartoon
  • My Space
  • Reviews
  • Education Today
  • Property
  • Lifestyle
Home | Business | Natco Pharma Board Okays Acquiring 1 In Canadian Arm

Natco Pharma board okays acquiring 1% in Canadian arm

Stocks of Natco Pharma were trading 0.74 per cent lower at Rs 810.85 apiece on BSE. 

By PTI
Published Date - 26 March 2021, 05:56 PM
Natco Pharma board okays acquiring 1% in Canadian arm
whatsapp facebook twitter telegram

New Delhi: Drug major Natco Pharma on Friday said its board has approved acquiring about 1 per cent stake in its Canadian subsidiary.

The company, however, did not disclose the value of the deal. “The board of directors of the company at their meeting approved to acquire 0.96 per cent stake in Natco Pharma (Canada) Inc., after this acquisition Natco Pharma (Canada) Inc., (will) become a wholly owned subsidiary company of Natco Pharma Ltd,” Hyderabad-based Natco Pharma said in a regulatory filing.


The company did not share any more details. Stocks of Natco Pharma were trading 0.74 per cent lower at Rs 810.85 apiece on BSE.

  • Follow Us :
  • Tags
  • Canadian subsidiary
  • Hyderabad-based Natco Pharma
  • Natco Pharma
  • regulatory filing

Related News

  • Hyderabad-based Natco Pharma, Hetero Labs, Dr Reddy’s arm bag generic drug contracts in China

    Hyderabad-based Natco Pharma, Hetero Labs, Dr Reddy’s arm bag generic drug contracts in China

  • Hyderabad-based Natco Pharma offers to acquire nearly 36 per cent stake in Adcock Ingram in Rs 2,100-crore deal

    Hyderabad-based Natco Pharma offers to acquire nearly 36 per cent stake in Adcock Ingram in Rs 2,100-crore deal

  • Hyderabad-based Natco Pharma shares crash 19 per cent on poor financial results

    Hyderabad-based Natco Pharma shares crash 19 per cent on poor financial results

  • Hyderabad-based Natco Pharma gets FDA approval for marketing Bosentan Tablets in the United States

    Hyderabad-based Natco Pharma gets FDA approval for marketing Bosentan Tablets in the United States

Latest News

  • Char Dham Yatra sees record pilgrim footfall in Uttarakhand

    27 minutes ago
  • Gulf War: UAE stresses diplomacy to resolve disputes

    38 minutes ago
  • Four ISIS operatives sentenced to up to six years in ‘Voice of Hind’ case

    47 minutes ago
  • Hyderabad: Man allegedly strangled to death by woman, associates in Mangalhat

    1 hour ago
  • Railways beat Andhra Pradesh to win 12th ball badminton title

    1 hour ago
  • Opinion: From signatures to equality—the historic journey of women’s voices in New Zealand

    1 hour ago
  • Editorial: EC forced into damage-control mode

    2 hours ago
  • Hyderabad: Three arrested for murder of 34-year-old man in Upperpally

    2 hours ago

company

  • Home
  • About Us
  • Contact Us
  • Privacy Policy

business

  • Subscribe

telangana today

  • Telangana
  • Hyderabad
  • Latest News
  • Entertainment
  • World
  • Andhra Pradesh
  • Science & Tech
  • Sport

follow us

  • Telangana Today Telangana Today
Telangana Today Telangana Today

© Copyrights 2024 TELANGANA PUBLICATIONS PVT. LTD. All rights reserved. Powered by Veegam

Telangana Today App